HUE058995T2 - Szubsztituált imidazokinolinok mint a TLR7 agonistái - Google Patents

Szubsztituált imidazokinolinok mint a TLR7 agonistái

Info

Publication number
HUE058995T2
HUE058995T2 HUE18769603A HUE18769603A HUE058995T2 HU E058995 T2 HUE058995 T2 HU E058995T2 HU E18769603 A HUE18769603 A HU E18769603A HU E18769603 A HUE18769603 A HU E18769603A HU E058995 T2 HUE058995 T2 HU E058995T2
Authority
HU
Hungary
Prior art keywords
tlr7
agonists
substituted imidazoquinolines
imidazoquinolines
substituted
Prior art date
Application number
HUE18769603A
Other languages
English (en)
Inventor
Christophe Henry
Original Assignee
BioNTech SE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BioNTech SE filed Critical BioNTech SE
Publication of HUE058995T2 publication Critical patent/HUE058995T2/hu

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/4738Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
HUE18769603A 2017-09-06 2018-08-31 Szubsztituált imidazokinolinok mint a TLR7 agonistái HUE058995T2 (hu)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP2017072353 2017-09-06

Publications (1)

Publication Number Publication Date
HUE058995T2 true HUE058995T2 (hu) 2022-10-28

Family

ID=63586658

Family Applications (1)

Application Number Title Priority Date Filing Date
HUE18769603A HUE058995T2 (hu) 2017-09-06 2018-08-31 Szubsztituált imidazokinolinok mint a TLR7 agonistái

Country Status (22)

Country Link
US (2) US11279684B2 (hu)
EP (2) EP4098652A1 (hu)
JP (1) JP7304848B2 (hu)
KR (1) KR20200050964A (hu)
CN (1) CN111132969B (hu)
AU (1) AU2018329152B2 (hu)
BR (1) BR112020004505A2 (hu)
CA (1) CA3074611A1 (hu)
DK (1) DK3679025T3 (hu)
ES (1) ES2914800T3 (hu)
HR (1) HRP20220669T1 (hu)
HU (1) HUE058995T2 (hu)
IL (1) IL273039B2 (hu)
LT (1) LT3679025T (hu)
MX (1) MX2020002366A (hu)
PL (1) PL3679025T3 (hu)
PT (1) PT3679025T (hu)
RS (1) RS63265B1 (hu)
SG (1) SG11202001926QA (hu)
SI (1) SI3679025T1 (hu)
WO (1) WO2019048353A1 (hu)
ZA (2) ZA202001267B (hu)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10618896B2 (en) 2017-08-22 2020-04-14 Dynavax Technologies Corporation Alkyl chain modified imidazoquinoline TLR7/8 agonist compounds and uses thereof
WO2019048036A1 (en) * 2017-09-06 2019-03-14 Biontech Ag SUBSTITUTED IMIDAZOQUINOLINES
CU24679B1 (es) * 2019-03-07 2023-09-07 BioNTech SE Proceso para la preparación de una imidazoquinolina sustituida
EP4178574A4 (en) * 2020-07-08 2024-04-10 Purdue Research Foundation COMPOUNDS, COMPOSITIONS AND METHODS FOR TREATING FIBROTIC DISEASES AND CANCER

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6573273B1 (en) 1999-06-10 2003-06-03 3M Innovative Properties Company Urea substituted imidazoquinolines
US6451810B1 (en) 1999-06-10 2002-09-17 3M Innovative Properties Company Amide substituted imidazoquinolines
US6756382B2 (en) 1999-06-10 2004-06-29 3M Innovative Properties Company Amide substituted imidazoquinolines
US6677349B1 (en) 2001-12-21 2004-01-13 3M Innovative Properties Company Sulfonamide and sulfamide substituted imidazoquinolines
MY157827A (en) 2003-06-27 2016-07-29 3M Innovative Properties Co Sulfonamide substituted imidazoquinolines
JP2007512349A (ja) * 2003-11-25 2007-05-17 スリーエム イノベイティブ プロパティズ カンパニー ヒドロキシルアミンおよびオキシム置換した、イミダゾキノリン、イミダゾピリジン、およびイミダゾナフチリジン
ES2667054T3 (es) * 2008-03-24 2018-05-09 Biontech Ag Nuevas imidazoquinolinas sustituidas
CA2996213C (en) 2015-08-31 2023-10-03 3M Innovative Properties Company Guanidine substituted imidazo[4,5-c] ring compounds
WO2019048036A1 (en) * 2017-09-06 2019-03-14 Biontech Ag SUBSTITUTED IMIDAZOQUINOLINES

Also Published As

Publication number Publication date
EP3679025A1 (en) 2020-07-15
US11279684B2 (en) 2022-03-22
IL273039B2 (en) 2023-10-01
EP3679025B8 (en) 2022-06-15
US20220242845A1 (en) 2022-08-04
RS63265B1 (sr) 2022-06-30
US11987569B2 (en) 2024-05-21
WO2019048353A1 (en) 2019-03-14
AU2018329152B2 (en) 2024-02-15
CN111132969B (zh) 2024-01-30
ZA202101323B (en) 2022-09-28
DK3679025T3 (da) 2022-06-07
US20210002249A1 (en) 2021-01-07
IL273039B1 (en) 2023-06-01
ZA202001267B (en) 2021-07-28
KR20200050964A (ko) 2020-05-12
IL273039A (en) 2020-04-30
AU2018329152A1 (en) 2020-03-19
HRP20220669T1 (hr) 2022-08-19
CN111132969A (zh) 2020-05-08
JP2020532571A (ja) 2020-11-12
PL3679025T3 (pl) 2022-07-11
PT3679025T (pt) 2022-06-01
LT3679025T (lt) 2022-06-27
EP3679025B1 (en) 2022-05-04
SG11202001926QA (en) 2020-04-29
RU2020112231A (ru) 2021-10-06
CA3074611A1 (en) 2019-03-14
ES2914800T3 (es) 2022-06-16
EP4098652A1 (en) 2022-12-07
MX2020002366A (es) 2020-07-20
BR112020004505A2 (pt) 2020-09-15
JP7304848B2 (ja) 2023-07-07
SI3679025T1 (sl) 2022-07-29
RU2020112231A3 (hu) 2021-10-06

Similar Documents

Publication Publication Date Title
IL272888B1 (en) Uses of piperidinyl-indole derivatives
SG11201706729SA (en) Derivatives of sobetirome
IL263050B (en) History of Subtirum
ZA202101323B (en) Substituted imidazoquinolines as agonists of tlr7
EP3386935A4 (en) PREPARATION OF XYLENE DERIVATIVES
FI3943070T3 (fi) Pitkävaikutteisia bedakiliiniformulaatioita
ZA202101322B (en) Substituted imidazoquinolines
GB201511156D0 (en) Production of alkaloids
IL278933A (en) TLR7 agonists
IL293192A (en) Methods for the preparation of indolinobenzodiazepine derivatives
IL270703B1 (en) History of Reziquimod
IL255182A0 (en) History of korormicim with antibiotic use
IL266121A (en) A history of metamorphosed quinoxaline as an inhibitor of pfkfb
GB201520346D0 (en) Stable amorphous form of daclatasvir
HK1247826A1 (zh) 吡咯甲酰胺的固體組合物
GB201502834D0 (en) Composition of objects
HUP1400294A2 (hu) Clopidogrel új alkalmazása
GB201412359D0 (en) Composition of objects
GB201412089D0 (en) Composition of objects